drugset / Trial / NCT02685436

Role of Pepsin Assay in Wheezy Infants

NCT02685436

Phase 4 Completed 52 enrolled Mansoura University Children Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

Wheezy infants were tested for gastro-esophageal reflux disease (GERD) using combined multiple channel intraluminal impedance-pH (MII-pH), esophagogastroduodenoscope (EGD), lipid laden macrophage index and BAL pepsin. Wheezy infants with abnormal MII-pH or reflux esophagitis were given domperidone and omeprazole then re-evaluated for symptoms control and exacerbations recurrence.

Timeline

Start
2013-03
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 0.2 mg/kg
Subject Omeprazole Other / unclassified 10 mg